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Introduction
Skeletal muscle tissue is characterized by a very slow turnover. 
Turnover increases, however, upon certain physiological stimuli 
or in pathological conditions, such as primary myopathies, lead-
ing to an extensive repair process aimed at preventing the loss 
of muscle mass.
The initial phase of muscle repair is characterized by ne-
crosis of the damaged tissue and activation of an infl  ammatory 
response (Charge and Rudnicki, 2004). Local cues, produced by 
growth factors and infl  ammatory cytokines released by infi  ltrat-
ing cells, lead to the activation of quiescent myogenic cells, the 
satellite cells located beneath the basal lamina of muscle fi  bers 
that start to proliferate, differentiate, and fuse, leading to new 
myofi  ber formation and reconstitution of a functional contrac-
tile apparatus.
Muscle satellite cell activation resembles embryonic myo-
genesis in several ways, including the de novo induction of the 
myogenic regulatory factors (MRF). Genetic studies have de-
fi  ned a temporal and functional hierarchy among the myogenic 
basic helix-loop-helix transcription factors during somitic myo-
genesis, the fi  rst of which are Myf5 and MyoD (Cossu and 
Biressi, 2005; Buckingham et al., 2006). Quiescent satellite cells 
express another important transcription factor, Pax7, which is 
involved in myogenic specifi  cation (Relaix et al., 2006; Kuang 
et al., 2007). Upon injury, satellite cells are activated and start 
proliferating and expressing Myf5 and MyoD, whereas Pax7 ex-
pression is progressively reduced. At this stage they are often re-
ferred to as myogenic precursor cells. Subsequently, expression 
of myogenin and MRF4 (MRF members) is up-regulated in cells 
beginning their terminal differentiation program, which is fol-
lowed by permanent exit from the cell cycle, activation of 
muscle-specifi  c proteins such as sarcomeric myosin, and fusion 
with damaged muscle fi  bers or with themselves, to produce new 
fi  bers that replace the dead ones. A fraction of activated cells 
down-regulates expression of Myf5/MyoD and returns to a qui-
escent state to maintain a more or less constant pool of satellite 
cells. A delicate balance between cell proliferation and exit from 
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  R
egeneration of muscle ﬁ   bers that are lost during 
pathological muscle degeneration or after injuries is 
sustained by the production of new myoﬁ   bers. 
An important cell type involved in muscle regeneration is 
the satellite cell. Necdin is a protein expressed in satel-
lite  cell–derived myogenic precursors during perinatal 
growth. However, its function in myogenesis is not known. 
We compare transgenic mice that overexpress necdin in 
skeletal muscle with both wild-type and necdin null mice. 
After muscle injury the necdin null mice show a consider-
able defect in muscle healing, whereas mice that over-
express necdin show a substantial increase in myoﬁ  ber 
regeneration. We also ﬁ  nd that in muscle, necdin increases 
myogenin expression, accelerates differentiation, and coun-
teracts myoblast apoptosis. Collectively, these data clarify 
the function and mechanism of necdin in skeletal muscle 
and show the importance of necdin in muscle regeneration.
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Figure 1.  Necdin is expressed during adult myogenic differentiation. (A–C) Immunoﬂ  uorescence on TA sections from P5 mice, using antibodies 
speciﬁ  c for necdin (green; A) or Myf5 (red; C). Nuclei are stained with DAPI (B). (D) The merged image of A, B, and C. (E–G) Immunoﬂ  uorescence on 
TA sections from P10 mice using antibodies speciﬁ  c for necdin (green; E) or Myf5 (red; G). Nuclei are stained with DAPI (F). (H) The merged image of 
E, F, and G. (I) Muscles were isolated from 5-, 10-, and 15-d-old mice or 1-, 2-, and 3-mo-old mice. Necdin protein expression was analyzed by Western 
blot using a speciﬁ  c antibody and GAPDH expression was used as loading control. (J) Primary myoblasts were isolated, maintained for 24 h in growth 
medium (P), or differentiated for 1, 2, or 3 d. Necdin protein expression was analyzed by Western blot using a speciﬁ  c antibody. MyHC was used as a NECDIN AND MUSCLE REGENERATION • DEPONTI ET AL. 307
cell cycle, differentiation, and fusion is required for the correct 
muscle regeneration to occur, and many proteins have been 
found to play a crucial role in these processes, including insu-
lin-like growth factor, myostatin and follistatin (Musaro and 
Rosenthal, 1999; Lee and McPherron, 2001; Iezzi et al., 2004; 
Pisconti et al., 2006), intracellular mediators like p66 (Zaccagnini 
et al., 2004), and transcription factors other than MRF, such as 
E2F1 and myocyte nuclear factor (Garry et al., 2000; Li et al., 
2000; Yan et al., 2003).
Necdin is a member of the melanoma antigen-encoding 
gene family (Barker and Salehi, 2002), a large family of pro-
teins initially isolated from melanomas. The predominant fea-
ture of these proteins is a large central region termed the 
melanoma antigen-encoding homology domain. Defi  ciency of 
necdin in transgenic mice causes neonatal respiratory distress 
that is usually fatal, and surviving mice exhibit behavioral and 
cognitive disruptions that bear some resemblance to the phe-
notype observed in humans affected by the Prader Willi syn-
drome (Gerard et al., 1999; Muscatelli et al., 2000). Studies in 
neuroblastoma cell lines and dorsal root ganglia cultures have 
suggested that necdin may act as a growth suppressor, facilitat-
ing cell cycle exit and differentiation while inhibiting apopto-
sis in neurons (Muscatelli et al., 2000; Kobayashi et al., 2002; 
Takazaki et al., 2002; Kuwako et al., 2005). The precise cellu-
lar mechanism leading to cell cycle arrest is still unclear, al-
though evidence points to interaction with proteins involved in 
cell cycle progression such as p53 and E2F (Taniura et al., 
1999; Kuwako et al., 2004; Kurita et al., 2006; Kuwajima 
et al., 2006). We have also shown that necdin cooperates with 
the homeobox transcription factor Msx2 during smooth muscle 
differentiation of mesoangioblast cells (Brunelli et al., 2004). 
Whether necdin acts as a transcriptional cofactor or as a direct 
transcriptional repressor or activator in these different scenarios 
is still unknown.
Necdin is also expressed in developing skeletal muscle, 
which suggests that it plays a relevant role in this tissue (Brunelli 
et al., 2004; Kuwajima et al., 2004; Watrin et al., 2005). Its func-
tion in skeletal muscle and myogenesis, however, has not been 
investigated in detail.
Here, we provide the fi  rst evidence that necdin plays an 
important role in skeletal muscle growth and repair in vivo, as 
shown by using loss- and gain-of-function experiments in nec-
din knockout mice and mice overexpressing necdin specifi  cally 
in skeletal muscle. We also demonstrate that necdin activity is 
mediated through stimulation of myoblast differentiation and 
protection from apoptotic cell death.
Results
Necdin expression in adult skeletal muscle 
is restricted to myogenic precursor cells
To study the expression of necdin in postnatal skeletal muscle 
we performed immunofl  uorescence on cryostat sections of tibi-
alis anterior (TA) muscle from postnatal day (P) 5 and P10 pups 
(Fig. 1, A–H) and 2-mo-old mice (not depicted). In P5 (Fig. 1, 
A–D) and P10 (Fig. 1, E and F) muscle sections, we observed 
colocalization of necdin with Myf5-positive cells, indicating 
that these cells are myogenic precursor cells. No other cells in 
the muscle appeared to express necdin. We did not detect stain-
ing for necdin in 2-mo-old muscle (not depicted). Using West-
ern blot, we also analyzed the profi  le of necdin expression in TA 
muscle from mice at different ages. As indicated in Fig. 1 I, 
necdin expression was high in muscle from 5–10-d-old pups, it 
decreased in pups from 15 d to 1 mo old, and it was undetect-
able at 2–3 mo, in agreement with the immunofl  uorescence 
data. This suggests that necdin is restricted to active myogenic 
progenitor cells.
We isolated myoblasts from newborn mice and studied 
the temporal expression profi  le during differentiation. Prolifer-
ating myoblasts expressed high levels of necdin, which de-
creased as differentiation proceeded, along with increased 
expression of sarcomeric myosin and decreased expression of 
the proliferation marker proliferating cell nuclear antigen 
(PCNA; Fig. 1 J).
We also isolated single muscle fi  bers from 2-mo-old 
mice and analyzed the expression of necdin, together with that 
of Pax7, a marker of quiescent satellite cells and early myo-
genic progenitors, and of MyoD, a marker of activated satellite 
cells and myogenic precursor cells (Cooper et al., 1999; 
Tajbakhsh, 2005; Relaix et al., 2006; Kuang et al., 2007). Expres-
sion of necdin and these two markers was analyzed from cells 
on a single fi  ber or from cells that migrated away from the 
fi  ber, which were subsequently maintained in proliferating or 
differentiating medium. We found that necdin was coexpressed 
with Pax7 in very few cells (Fig. 1, K–L; and Fig. S1, A–D; avail-
able at http://www.jcb.org/cgi/content/full/jcb.200701027/DC1). 
In most cases it was coexpressed with MyoD (Fig. 1, M and N, 
Q–S’, and T-U’). Necdin localization was in the cytoplasm 
but staining was also observed in some nuclei (Fig. 1, Q–S’ 
and T–U’) and in both cells on the fi  bers and cells leaving 
the fibers. In differentiated myotubes, the level of necdin 
expression was lower and predominantly in the cytoplasm 
(Fig. 1, O and P).
marker of myogenic differentiation, PCNA as a proliferation marker, and GAPDH as a loading control. (K–U’) Single muscle ﬁ  bers were isolated from 
2-mo-old mice and then either maintained in proliferation medium or switched to differentiation medium. (K–L) Immunoﬂ  uorescence on myoblasts de-
rived from single ﬁ  bers maintained in proliferation medium, using antibodies speciﬁ  c for necdin (green; K) and Pax7 (red; L). Nuclei in K are identiﬁ  ed 
by DAPI staining (blue). (M and N) Immunoﬂ  uorescence on myoblasts derived from single ﬁ  bers maintained in proliferation medium using antibodies 
speciﬁ  c for necdin (green; M) and MyoD (red; N). Nuclei in M are identiﬁ  ed by DAPI staining (blue). (O and P) Immunoﬂ  uorescence on myoblasts 
derived from single ﬁ  bers maintained in differentiation medium, using antibodies speciﬁ  c for necdin (green; O and P) and sarcomeric MyHC (red; P). 
Nuclei in O are identiﬁ  ed by DAPI staining (blue). (Q-S’) Immunoﬂ  uorescence on the single muscle ﬁ  ber using antibodies speciﬁ  c for necdin (green; Q, Q’, 
and S’) and MyoD (R and R’). Nuclei in S, R’, and S’ are identiﬁ  ed by DAPI staining (blue). In S, Q’, R’, and S’, the ﬂ  uorescence image is merged 
with the phase-contrast image. (T–U’) Immunoﬂ  uorescence on myoblasts derived from single ﬁ  bers maintained in proliferation medium, using antibodies 
speciﬁ  c for necdin (green; T–U’) and MyoD (red; U and U’). Nuclei in T’ are identiﬁ  ed by DAPI staining (blue). Bars: (A–D) 75 μm; (E–H) 150 μm; (K–P) 
100 μm; (Q–U’) 30 μm.JCB • VOLUME 179 • NUMBER 2 • 2007  308
Necdin is required for normal 
muscle growth
To investigate the role of necdin in myogenesis in vivo, we ana-
lyzed gain and loss of necdin function in transgenic mice.
We fi  rst generated a transgenic mouse overexpressing 
necdin in skeletal muscle. We cloned the ORF of necdin, down-
stream of the myosin light chain (MyLC) 1F promoter and 
upstream of the MyLC enhancer (Jiang et al., 2002; Fig. 2 A). 
The linearized vector was used to generate transgenic lines by 
pronuclear injection. Two founders, MlcNec2 and MlcNec9, 
screened by PCR and selected on the basis of transgene trans-
mission to the progeny, were maintained as two independent 
lines on a CBA/C57BL6 background (Fig. 2 B). We tested the 
expression of the transgene on tissues and myoblasts by 
RT-PCR using specifi  c primers (Fig. 2, C and U) and the over-
expression of the protein by immunofl  uorescence and Western 
blot (Fig. 2, D–T). The transgenic animals showed increased 
expression of necdin in isolated adult myogenic progenitors, 
and the protein was also found in different adult muscles (dia-
phragm, soleus, and TA) where levels of expression in the wild 
type (wt) were undetectable (Fig. 2, C and D). Of notice, the 
MyLC1F promoter, derived from the locus of a fast myosin-
type gene, was also able to drive necdin expression in the 
soleus, a muscle with an abundance of slow fi  bers. The transgene 
was expressed in both proliferating myoblasts and differentiat-
ing myotubes, indicating that the promoter also allows expres-
sion of this transgene in cells not terminally differentiated 
(Fig. 2 U). In addition, it was possible to observe expression of 
necdin in nuclei and also faintly in the fi  ber cytoplasm on sec-
tions of adult muscle (Fig. 2, E–H; and Fig. S2 E, available at 
http://www.jcb.org/cgi/content/full/jcb.200701027/DC1). In some 
cases, transgenic necdin colocalized with rare Myf5-positive 
activated satellite cells (Fig. 2, E–H). As in the case of wt, 
expression of necdin in myoblasts was both in the nucleus and 
cytoplasm (Fig. 2, I–L), and we could detect overexpression of 
necdin in the cytoplasm and nucleus of cells on single muscle 
fi  ber coexpressing MyoD (Fig. 2, M–T). The tissue specifi  city 
of the promoter and the transgene expression was verifi  ed by 
testing the expression of necdin in other tissues and organs 
where necdin is expressed at very low, barely detectable levels 
(lung, kidney, and heart; Fig. 2, C and D). The transgenic mice 
from both lines showed no overt differences in terms of weight, 
fertility, behavior, and life span with respect to the littermate 
controls (not depicted).
We decided to compare the results in these mice to the re-
sults of necdin loss-of-function transgenic mice, i.e., the Ndn
−/− 
mice (Muscatelli et al., 2000) obtained from Ndn
−/+ intercrosses. 
Necdin has been described as an imprinted gene, paternally 
expressed only, but the lack of expression from the maternal 
chromosome in myogenic cells has never been investigated. 
We performed analysis of necdin RNA and protein expression in 
brain and myoblasts from Ndn
−/−, Ndn
−m/+p, Ndn
+m/−p, and wt. 
We observed that heterozygous mice carrying the mutated gene 
on the paternal chromosome showed expression of necdin nei-
ther in brain nor in myoblasts, indicating that necdin also under-
goes complete maternal silencing in the myogenic lineage 
(Fig. 2, V and W).
To determine whether necdin plays a functional role in 
skeletal muscle in vivo, we examined myofi  ber size in wt, Ndn
−/−, 
and MlcNec2 muscles from P10 pups (Fig. 3, A–C, G, and I) and 
2-mo-old mice (Fig. 3, D–F, H, and J–O). The TA muscles were 
collected from adult wt, Ndn
−/−, and MlcNec2 mice. In the adult 
we also collected the soleus. Sections were stained with hema-
toxylin and eosin (H&E; Fig. 3, A–F). As confi  rmed by cross-
sectional area (XSA) analyses (Fig. 3, I–K), Ndn
−/− myofi  bers 
were signifi  cantly smaller than wt myofi  bers in both P10 and 
adult mice, whereas MlcNec2 myofi  bers were consistently larger, 
particularly in the adult (Fig. 3, G and H). We also determined the 
mean number of myofi  bers in TA and soleus muscle in the adult. 
We observed that MlcNec2 muscle contained a similar number 
of myofi  bers, whereas Ndn
−/− showed a higher number of fi  bers 
(Fig. 3, L and M). Finally, we measured the maximum XSA of 
the TA and soleus muscle; the results indicate that MlcNec2 mice 
have an increased XSA (Fig. 3, N and O). The effects of loss and 
gain of function of necdin on morphological parameters of mus-
cle was greater in the TA with respect to the soleus, refl  ecting 
the relative amount of necdin expression in the two muscles. 
All these data suggest that necdin is involved in myofi  ber growth 
and maintenance.
Necdin is required for efﬁ  cient muscle 
regeneration in vivo
To analyze the overall regeneration capacity of these mice, 
injury and regeneration were induced in the TA of 3-mo-old 
transgenic and wt mice by injecting 25 μl of 10 μM cardiotoxin 
(CTX). Mice were killed 3, 7, and 14 d after the CTX injection; 
the injured TA was cryostat sectioned and stained with H&E or 
Azan-Mallory.
In wt mice, new myotube formation in TA muscle was 
observed after 7 d (Fig. 4 B), even if infl  ammatory infi  ltrates 
were still present. In contrast, MlcNec2 mice displayed a more 
advanced rate of regeneration and formation of newly regenerated 
fi  bers by 3 d after the CTX injection (Fig. 4, E and F). The ac-
celerated regeneration in MlcNec2 mice was accompanied by 
high expression of neonatal myosin, a marker of muscle regen-
eration in the adult (Fig. 4, K, L, and S). Conversely, Ndn
−/− 
mice showed a marked delay in the regeneration process with 
increased infl  ammatory infi  ltrates, decreased numbers of new 
regenerating, centronucleated fi  bers (Fig. 4, C and D), and no ex-
pression of neonatal myosin (Fig. 4, I and J) with respect to the 
wt muscle (Fig. 4, G and H). 14 d after the crush, the overall archi-
tecture was completely restored in the wt, MlcNec2, and Ndn
−/− 
muscle, and they were undistinguishable from uninjured muscle 
except for centrally located nuclei (Fig. 4, M, O, and Q).
To further investigate whether delayed regeneration in 
Ndn
−/− mice may indicate a major defect in this process, we 
caused more severe damage by injecting 100 μM CTX, a higher 
concentration than before. We analyzed the mice after 14 d and 
observed that in wt animals, regeneration was occurring normally, 
even if infl  ammatory infi  ltrates were still present (Fig. 4 N). 
In contrast, MlcNec2 mice showed a complete regeneration of 
the muscle (Fig. 4 R). A dramatic effect was seen on the Ndn
−/− 
animal. At dissection, the injured TA already appeared atrophic 
(not depicted) and no regenerating fi  bers were seen (Fig. 4 P). NECDIN AND MUSCLE REGENERATION • DEPONTI ET AL. 309
Figure 2.  Analysis of the expression of necdin in the gain- and loss-of-function transgenic mice. (A) Map of the gain-of-function transgene; arrows indicate 
the primers for the genotyping. (B) PCR analysis of the MlcNec2 transgenic mice using primers speciﬁ  c for the transgene (MlcNec tg). (C) Expression of 
MlcNec tg and GAPDH by RT-PCR analysis, using speciﬁ  c primers on total RNA from kidney (Ki), diaphragm (Dia), and TA from 2-mo-old MlCNec2 trans-
genic mice or wt littermates. (D) Expression of necdin and GAPDH by Western blot analysis using speciﬁ  c antibodies on protein extract from lung, heart, 
diaphragm, soleus (So), and TA from 2-mo-old MlCNec2 transgenic mice or wt littermates, or primary myoblasts (Myo) from newborn transgenic or wt mice. 
(E–G) Immunoﬂ  uorescence on TA sections from MlcNEc2 2-mo-old mice using antibodies speciﬁ  c for necdin (green; E) or Myf5 (red; G). Nuclei are stained 
with DAPI (F). (H) The merged image of E, F, and G. Arrowheads point to a double Myf5/necdin-positive myogenic precursor. (I–K) Immunoﬂ  uorescence 
on myoblasts cells from MlcNec2 newborn mice, using antibodies speciﬁ  c for necdin (green; I) and MyoD (red; K). Nuclei are stained with DAPI (J). (L) The 
merged image of I, J, and K. (M–T) Immunoﬂ  uorescence on a single muscle ﬁ  ber from 2-mo-old MlcNec2 mice, using an antibody speciﬁ  c for necdin (green; 
M and Q) and MyoD (red; O and S), showing single activated satellite cells. Nuclei are stained with DAPI (N and R). P and T show the merged images of 
M, N, and O and Q, R, and S, respectively. (U) Expression of necdin (ndn), MlcNec tg, MyLC, and GAPDH by RT-PCR analysis, using speciﬁ  c primers on 
total RNA from myoblasts from newborn wt or MlcNec2 mice, kept in proliferation medium for 24 h (0) or differentiated for 24 and 48 h. For the detection 
of necdin, PCR reaction was stopped at 28 cycles. A low level of MyLC transcript can be observed in both wt and transgenic myoblasts kept in proliferation 
medium. (V) Expression of ndn analyzed by RT-PCR, using speciﬁ  c primers on RNA from brain or primary myoblasts (My) from wt, Ndn
−m/+p, Ndn
+m/−p, 
or Ndn
−/− newborn mice. (W) Expression of necdin analyzed by Western blot, using a speciﬁ  c antibody on protein extract from brain or primary myoblasts 
from wt, Ndn
−m/+p, or Ndn
+m/−p newborn mice. Bars: (E–H) 75 μM; (I–T) 50 μM.JCB • VOLUME 179 • NUMBER 2 • 2007  310
Figure 3.  Myoﬁ  ber XSAs are decreased in Ndn
−/− muscle and increased in MlcNec2 muscle. (A–C) Representative sections of wt (A), Ndn
−/− (B), and 
MlcNec2 (C) TA muscles from P10 mice stained with H&E. (D–F) Representative sections of wt (D), Ndn
−/− (E), and MlcNec2 (F) TA muscles from 2-mo-old 
(p60) mice stained with H&E. (G) Frequency histogram showing the distribution of myoﬁ  ber XSA in wt (n = 867 myoﬁ  bers), Ndn
−/− (n = 954 myoﬁ  bers), 
and MlcNec2 (n = 890 myoﬁ  bers) TA muscles from P10 mice. (H) Frequency histogram showing the distribution of myoﬁ  ber XSA in wt (n = 987 myoﬁ  bers), 
Ndn
−/− (n = 1,023 myoﬁ  bers), and MlcNec2 (n = 997 myoﬁ  bers) TA muscles from 2-mo-old mice. (I) Mean myoﬁ  ber XSA was calculated for wt, Ndn
−/−, 
and MlcNec2 TA muscles from P10 mice. The mean XSA of Ndn
−/− TA myoﬁ  bers was reduced by 28.4% compared with wt, whereas the mean XSA of 
MlcNec2 TA myoﬁ  ber was increased by 11.0%. n = 4 per genotype. (J) Mean myoﬁ  ber XSA was calculated for wt, Ndn
−/−, and MlcNec2 TA muscles 
from 2-mo-old mice. The mean XSA of Ndn
−/− TA myoﬁ  bers was reduced by 26.2% compared with wt, whereas the mean XSA of MlcNecc2 TA myoﬁ  ber NECDIN AND MUSCLE REGENERATION • DEPONTI ET AL. 311
The muscle was mostly composed of necrotic fi  bers in the pres-
ence of massive infl  ammatory infi  ltrates. As expected, no ex-
pression of neonatal myosin could be observed even by RT-PCR 
(Fig. 4 T). We also extended the analysis at 30 d after severe 
damage and observed similar results (Fig. S2 and not depicted).
These results indicate that necdin enhances the regenera-
tion of muscle after damage and that it is necessary to the regen-
eration process when the damage is severe. This observation 
strongly suggests that necdin may increase proliferation and/
or differentiation and/or protect the myogenic progenitor cells 
from apoptosis.
Necdin accelerates myogenic progenitor 
cell differentiation and fusion
We performed several experiments in vitro to investigate in 
more detail the mechanism through which necdin exerts its 
effects on myogenesis.
Myoblasts from newborn transgenic MlcNec2 mice, Ndn
−/−, 
and wt littermates were isolated as described in Sabourin et al. 
(1999) and seeded at clonal density. Cells were either main-
tained in proliferation medium or switched to differentiation 
medium. At different time points we either obtained cell lysates 
for Western analysis or we fi  xed the cells and performed immuno-
fl  uorescence using the MF20 antibody that recognizes the 
sarcomeric myosin heavy chain (MyHC). Myoblasts cultured 
from MlcNec2 mice initiated differentiation more rapidly and 
formed myotubes with an increased fusion index with respect to 
wt controls (Fig. 5, A and B). Myoblasts cultured from Ndn
−/− 
mice consistently showed a reduced differentiation and fusion 
index (Fig. 5, A and B).
We also investigated the effect of necdin overexpression 
in myoblasts by infecting wt newborn myoblasts with a lentivi-
ral vector expressing necdin under the cytomegalovirus consti-
tutive promoter (pLentiNecdinIRESGFP) or the empty vector 
(pLentiIRESGFP). Cells were infected 24 h after plating at 
clonal density, and then maintained in proliferation medium for 
72 h. We did not observe any effect on myoblast proliferation or 
number and size of the clones generated (not depicted), but nec-
din-overexpressing myoblasts underwent spontaneous differen-
tiation, forming myotubes with an increased fusion index with 
respect to controls (Fig. S3, A–F, available at http://www.jcb
.org/cgi/content/full/jcb.200701027/DC1). A similar effect on 
differentiation was also seen in C2C12 cells after transfection 
with a necdin-expressing vector (Fig. S3, G–L).
Increased or reduced differentiation of myoblasts may de-
pend on changed expression of MRF and/or decreased cell death. 
We decided to investigate which of these parameters was altered 
by fi  rst analyzing the protein levels of MyoD, myogenin, and 
sarcomeric MyHC (Fig. 5, C and D). The increased and decreased 
differentiation levels we observed in the myoblast cultures from 
MlcNec2 and Ndn
−/− mice, respectively, were accompanied by 
increased and decreased expression of MyHC, respectively. 
Interestingly, MyoD was more highly expressed in Ndn
−/− satellite 
cells, possibly refl  ecting an accumulation of myoblasts, whereas 
myogenin expression at the beginning of differentiation in the 
MlcNec2 cultures was signifi   cantly increased in comparison 
with wt and even more so in comparison with Ndn
−/−.
Necdin has been described as acting both as a coactivator 
and a corepressor of transcription mediated by other transcription 
factors (Kuwako et al., 2004; Kurita et al., 2006; Kuwajima et al., 
2006). To determine whether the modifi  ed expression of myo-
genic markers was caused by a direct transcriptional activation of 
these genes by necdin, we tested the ability of this protein to trans-
activate the myogenin promoter–driving expression of a chloram-
phenicol acetyltransferase (CAT) reporter gene by cotransfecting 
a necdin expression construct (pIRES-GFP-necdin; Brunelli et al., 
2004) together with the reporter construct pMyo-1565CAT 
(Edmondson et al., 1992) in 10T1/2 or C2C12 cells. We observed 
that in C2C12, where the myogenin promoter already had a high 
basal activity caused by the presence of endogenous myogenic 
factors such as MyoD, necdin alone was able to activate four- to 
fi  vefold the expression of the CAT reporter (Fig. 5 E). In contrast, 
necdin was unable to activate the reporter gene when transfected 
alone in 10T1/2, but when necdin was cotransfected with a MyoD-
expressing construct (Edmondson et al., 1992), it increased CAT 
activity fi  vefold in comparison with MyoD alone. These results 
indicate that necdin is involved in the transcriptional regulation of 
myogenic genes by cooperating with other MRFs.
We decided to investigate the mechanism of action of 
necdin by analyzing its ability to bind and/or interact with the 
myogenin promoter. C2C12 cells were transfected with the 
necdin overexpressing construct pCMV3B-Myc-necdin, and chro-
matin immunoprecipitation was performed using anti-necdin, 
anti-Myc, and anti-MyoD–specifi  c antibodies. As expected, we 
found that MyoD was able to bind to the myogenin promoter 
(Fig. 5 F). Interestingly, necdin was also equally able to bind this 
DNA sequence, which was precipitated both by anti-necdin or 
anti-Myc antibodies (Fig. 5 F).
was increased by 36.3%. n = 6 per genotype. (K) Mean myoﬁ  ber XSA was calculated for wt, Ndn
−/−, and MlcNec2 soleus muscles from 2-mo-old mice. 
The mean XSA of Ndn
−/− soleus myoﬁ  bers was reduced by 19.8% compared with wt, whereas the mean XSA of MlcNec2 soleus myoﬁ  ber was in-
creased by 25.0%. n = 6 per genotype. (L) Mean number of myoﬁ  bers per muscle was calculated for wt, Ndn
−/−, and MlcNec2 TA muscles from 2-mo-
old mice. No signiﬁ  cant difference was observed in the mean number of myoﬁ  bers between MlcNec2 and wt TA muscles, whereas there was a slight 
but signiﬁ  cant increase in the mean number of myoﬁ  bers (14.1%) in the Ndn
−/− TA muscle with respect to the wt. n = 6 per genotype. (M) Mean number 
of myoﬁ  bers per muscle was calculated for wt, Ndn
−/−, and MlcNec2 soleus muscles from 2-mo-old mice. No signiﬁ  cant difference was observed in the 
mean number of myoﬁ  bers between MlcNec2 and wt soleus muscles, whereas there was a slight but signiﬁ  cant increase in the mean number of myoﬁ  bers 
(12.2%) in the Ndn
−/− soleus muscle with respect to the wt. n = 6 per genotype. (N) Mean ﬁ  ber XSA was calculated for wt, Ndn
−/−, and MlcNec2 TA 
muscles from 2-mo-old mice at the level of maximum XSA. No signiﬁ  cant difference was observed in the mean ﬁ  ber XSA between Ndn
−/− and wt TA 
muscles, whereas there was a signiﬁ  cant increase in the mean XSA (15.5%) in the MlcNec2 TA with respect to the wt. n = 6 per genotype. (O) Mean 
ﬁ  ber XSA was calculated for wt, Ndn
−/−, and MlcNec2 soleus muscles from 2-mo-old mice at the level of maximum XSA. No signiﬁ  cant difference was 
observed in the mean ﬁ  ber XSA between Ndn
−/− and wt soleus muscles, although there was a signiﬁ  cant increase in the mean XSA (11.5%) in the MlcNec2 
soleus with respect to the wt. n = 6 per genotype. Error bars represent SEM. ***, P < 0.001; **, P < 0.01; *, P < 0.05 versus wt. Bars: (A–C) 250 μm; 
(D–F) 500 μm.JCB • VOLUME 179 • NUMBER 2 • 2007  312
Figure 4.  Necdin is required for normal muscle regeneration after injury. (A–F) 3 (A, C, and E) and 7 d (B, D, and F) after CTX injury, wt (A and B), Ndn
−/− 
(C and D), and MlcNec2 (E and F) TA sections were stained with Azan Mallory. Representative sections are shown. (G–L) 3 d after CTX injury, neonatal 
myosin (nMHC) expression was analyzed by immunoﬂ  uorescence (red) using a speciﬁ  c antibody on wt (G and H), Ndn
−/− (I and J), and MlcNec2 (K and L) 
TA sections. Laminin expression (green) was also analyzed (G, I, and K). Nuclei are identiﬁ  ed with DAPI staining. (M–R) 14 d after injection with 10 (M, O, 
and Q) or 100 μM CTX (N, P, and R), wt (M and N), Ndn
−/− (O and P), and MlcNec2 (Q and R) TA sections were stained with H&E. Representative 
sections are shown. (S) Expression of necdin, MlcNec tg, nMHC, and GAPDH by RT-PCR on RNA from TA muscle from wt and MlcNec2 mice, before (writ-
ten as C) and 1, 3, and 7 d after CTX injection. (T) Expression of nMHC and GAPDH by RT-PCR on RNA from TA muscle from wt, Ndn
−/−, and MlcNec2 
mice 14 d after injection with 10 or 100 μM CTX. Bars: (A–F) 400 μm; (G–L) 200 μm; (M–R) 300 μm.NECDIN AND MUSCLE REGENERATION • DEPONTI ET AL. 313
We then wanted to investigate whether necdin was able to 
directly interact with other proteins known to bind the myogenin 
promoter, e.g., MyoD, myogenin, and Mef2A. We performed co-
immunoprecipitation experiments on C2C12 cells transfected with 
the same necdin-Myc–overexpressing construct. As shown in. 
Fig. S4 A (available at http://www.jcb.org/cgi/content/full/jcb
.200701027/DC1), we did not detect any direct interaction between 
necdin and MyoD, myogenin, or Mef2A in these conditions.
Necdin protects myoblasts from apoptosis
In neural cells, necdin protects against apoptosis, even if the 
mechanism is not completely clear (Muscatelli et al., 2000; 
Takazaki et al., 2002; Kuwako et al., 2005; Andrieu et al., 2006). 
Based on this observation in neural cells, we studied whether 
necdin protected myoblasts from apoptosis, and whether such 
protection contributed to accelerated regeneration in vivo in the 
MlcNec2 mice and delayed regeneration in the Ndn
−/− animals.
Figure 5.  Necdin accelerates differentiation and cooperates with MyoD in myogenin transcriptional activation. (A and B) Primary myoblasts from wt, 
Ndn
−/−, and MlcNec2 newborn mice were maintained for 24 h in growth medium and differentiated for 16 or 48 h, and then immunoﬂ  uorescence was 
performed using a MyHC-speciﬁ  c antibody. (A) Fusion index (percentage of nuclei within MyHC-positive myotubes with more than two nuclei) was calcu-
lated after 16 and 48 h in differentiation medium. Error bars represent SEM. ***, P < 0.001 versus wt. (B) Representative images of immunoﬂ  uorescence 
on wt, Ndn
−/−, and MlcNec2 myoblast culture after 16 h in differentiation medium, using an antibody speciﬁ  c for sarcomeric MyHC (top). Nuclei in the 
bottom panels are visualized with DAPI. Bar, 100 μm. (C and D) Expression of MyoD, myogenin, and MyHC by Western blot analysis from myoblasts 
maintained in proliferation medium (P) or differentiated for 16 or 30 h. (C) Densitometric analysis of Western blot with the bands normalized for GAPDH 
expression (n = 4). Error bars represent SEM. ***, P < 0.001; **, P < 0.01; *, P < 0.05 versus wt. (D) Representative image of a Western blot. 
(E) C2C12 and 10T1/2 cell were transfected with or without myogenin-CAT (pMyo-1565CAT), pIRESNecdin, and pEMSV-MyoD1. CAT activity was measured 
after 48 h (in proliferation medium for 10T1/2 and in differentiation medium for C2C12) by ELISA assay. (n = 6). ***, P < 0.01 myogenin-CAT only; 
+++, P > 0.01 versus myogenin-CAT + PCMV MyoD. (F) Soluble chromatin was prepared from cultures of C2C12 myoblasts transfected with pCMVNecdin-
Myc, differentiated for 48 h in differentiating medium, and immunoprecipitated with antibodies speciﬁ  c for MyoD, necdin, or Myc. Parallel extracts were 
exposed to rabbit IgG to control for nonspeciﬁ  c precipitation of chromatin. Precipitated genomic DNA was analyzed by PCR, using primers designed to 
amplify sequences in the myogenin promoter. Input refers to DNA input control in which PCR ampliﬁ  cation was performed before immunoprecipitation. 
A sample where no antibody was used for immunoprecipitation was run in parallel (noImmune).JCB • VOLUME 179 • NUMBER 2 • 2007  314
We used TUNEL assay to measure the level of cell death 
in CTX-injured muscles (Fig. 6, A and B). We observed an 
increased TUNEL staining in Ndn
−/− TA muscle with respect to 
wt (Fig. 6 A), whereas MlcNec2 showed a decreased number of 
TUNEL-positive cells (Fig. 6 A). We confi  rmed that satellite 
cell–derived myoblasts were among the TUNEL-positive cells 
as demonstrated by expression of nLacZ in a Myf5
nLacZ/+ back-
ground (Fig. S4, B–E; and not depicted).
We then investigated whether overexpression of necdin 
had prosurvival effects on myoblasts in vitro. To this end, wt, 
Ndn
−/−, and MlcNec2 myoblasts were exposed for a further 24 h 
to 20 μM of the cytotoxic stimuli staurosporine or 100 μM of 
the reactive oxygen species generating agent H2O2, or exposed 
for 1 min to UV radiation. Cell death was determined 24 h later 
by measuring both Annexin V staining of phosphatidylserine 
exposed on the outer leafl  et of the plasma membrane and prop-
idium iodide incorporation. Results obtained are summarized in 
Fig. 6 C, and representative dot plot analyses showing the re-
sults using H2O2 as the death-inducing stimulus are shown in 
Fig. 6 D. Cell death induction by all stimuli was decreased in 
MlcNec2 cells with respect to wt. On the contrary, cell death 
was increased in all conditions in the Ndn
−/− cells, including 
basal cell death. To investigate which cell death pathway necdin 
was involved in, we measured the levels of expression of the ac-
tivated effector caspase 3 and the initiating activated caspase 9, 
mainly involved in mitochondrial-mediated cell death (Perrotta 
et al., 2004). We observed that Ndn
−/− myoblasts challenged 
with either staurosporine or H2O2 display a higher level of acti-
vated caspase 9 and 3, with respect to wt cells, whereas acti-
vated caspase 3 and 9 were almost undetectable in MlcNec2 
myoblasts (Fig. 6 E). We observed a similar effect when C2C12 
myoblasts transfected with necdin where treated with the same 
apoptotic stimuli (Fig. S4 F).
Thus, necdin appears to act as a prosurvival factor in-
volved in the protection of cell death through inhibition of the 
mitochondrial cell death pathway.
Discussion
Stem cells are capable of both self-renewal and generating pro-
genitors that fi  nally undergo terminal differentiation to ensure 
the regeneration of tissues whose differentiated cells cannot 
divide. In tissues with a high cell turnover such as blood and 
skin, a constant fl  ow of precursors for terminal differentiation is 
needed. In contrast, adult skeletal muscle needs only new myo-
fi  bers for repair. In accordance, satellite cells are normally qui-
escent in adult muscle and activated only in response to specifi  c 
signals provoked by physiological or pathological stimuli. 
The activation of satellite cells and their subsequent progression 
through cell cycle, differentiation, and fusion need to be fi  nely 
regulated and tuned to ensure correct growth and maintenance 
of the fi  bers; therefore, understanding the molecular pathways 
involved in myoblast differentiation and survival is crucial to 
the development of treatments for impaired muscle growth 
associated with age, disease, and atrophy.
Here, we demonstrate that necdin is an important player 
in skeletal muscle differentiation and maintenance. We found 
that necdin acts on two different pathways: (1) it acts on myo-
blast differentiation through direct transcriptional regulation of 
myogenin, in cooperation with MyoD; and (2) it protects myo-
blasts from cell death.
Necdin and terminal differentiation
Necdin was initially identifi  ed as a nuclear protein expressed 
solely in neuronal tissue (Maruyama et al., 1991); subsequent 
studies demonstrated abundant necdin expression in the cyto-
plasm of differentiated neurons (Niinobe et al., 2000), in smooth 
muscle (Brunelli et al., 2004), and in brown adipocyte tissue 
(Boeuf et al., 2001). Necdin was initially identifi  ed by subtrac-
tion cloning in embryonic carcinoma cells induced to differenti-
ate into neurons by retinoic acid, where necdin expression 
increased markedly during early differentiation (Maruyama 
et al., 1991), and by overexpression of necdin in neuroblastoma 
cells, which both suppresses cell growth through inhibition of 
S phase entry (Taniura et al., 1998) and induces differentiation 
(Kobayashi et al., 2002; Takazaki et al., 2002).
The effect of necdin on differentiation may be cell type 
specifi  c. In contrast to neuronal cells, where growth arrest is 
required before fi  nal differentiation, adipocyte differentiation 
occurs with initial growth arrest, cell cycle reentry, and clonal 
expansion, followed by a second growth arrest and by terminal 
differentiation (Rangwala and Lazar, 2000). In these cells, in-
creased expression of necdin correlates with impaired differ-
entiation, and reduction of necdin expression restores the 
differentiation capacity, indicating an inhibitory effect of necdin 
on adipocyte differentiation (Tseng et al., 2005). This inhibition 
has also been associated with a down-regulation of adipocyte-
specifi  c prodifferentiation regulators, CEBP-α and PPAR-γ 
(Goldfi  ne et al., 2006). This suggests that necdin may act either 
by interfering with the cell cycle progression or by direct tran-
scriptional regulation of downstream target genes.
As in the case of adipocytes, satellite cells during the 
regeneration process undergo cell cycle reentry, expansion, and 
then terminal differentiation. Our results show that necdin is ex-
pressed in these cells upon activation and during the expansion 
phase, as it is coexpressed with Pax7 and MyoD. When myo-
blasts differentiate and start to fuse, necdin expression de-
creases. Continuous overexpression of necdin in differentiating 
myoblasts and in muscle fi  bers leads to signifi  cant hypertrophy 
of myotubes, myofi  bers, and muscle (Fig. 3, I–O; and Fig. 5 A). 
In addition, when muscle regeneration is induced in adult 
muscle after crush injury the reconstitution of new fi  bers is 
accelerated, indicating that myoblasts are actively differentiating. 
The gain-of-function effect in vitro in myoblast cultures corre-
lates with an increased fusion index and with changes in the ex-
pression of different myogenic markers, including myogenin 
and sarcomeric myosin. Conversely, necdin loss of function leads 
to the presence of smaller fi  bers, and when the muscle is dam-
aged the regeneration process is severely impaired. When dam-
age is severe, repair does not occur in the absence of necdin, 
indicating the obligatory role of this protein. The critical role of 
necdin appears not to be restricted to muscle because lack of 
necdin leads to altered motorneuron development (Pagliardini 
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necdin in motorneurons and skeletal muscle needs to be fur-
ther investigated.
Myoblasts from these mice show decreased levels of 
myogenin and myosin and a decreased fusion index when they 
differentiate. This suggests that necdin may be mainly re-
quired during the fi  rst phases of differentiation as well as in the 
growth and repair of the muscle fi  ber. Our results are consistent 
with this role, showing that necdin is highly expressed in the 
embryonic and fetal myoblasts (Biressi et al., 2007) and during 
the perinatal stages, whereas it decreases as postnatal develop-
ment proceeds.
In vitro data in 10T1/2 embryonic fi  broblast cells and 
C2C12 myoblast cells, using a reporter gene driven by myo-
genin promoter, indicated an enhancement of the transcrip-
tional activation achieved by MyoD or other MRFs. Necdin 
may therefore act by recruiting or stabilizing transcriptional 
Figure 6.  Necdin is required for myoblast survival in vivo and in vitro. (A and B) 3 d after CTX injury, TUNEL analysis was performed on TA sections of 
wt, Ndn
−/−, and MlcNec2 mice. (A) Representative sections are shown; in the top panels TUNEL staining is shown; in the bottom panels a merge with DAPI 
staining reveals nuclei. Bar, 400 μm. (B) Histogram representing the number of TUNEL-positive nuclei measured on serial TA sections. Values shown are 
the results of experiments on six animals per group, ± SEM. **, P < 0.01; * P < 0.05 versus wt. (C and D) Primary myoblasts from wt, Ndn
−/−, and 
MlcNec2 newborn mice were maintained for 24 h in growth medium and incubated for 24 h in the absence (NT) or presence of 5 μM Staurosporine (St) 
or 100 μM H2O2 or exposed to UV radiation for 1 min. (C) Cell death via apoptosis was determined by ﬂ  ow cytometry measuring Annexin V staining 
of phosphatidylserine exposed on the outer leaﬂ  et of the plasma membrane in propidium iodide–excluding cells (n = 4). Error bars represent SEM. ***, 
P < 0.001; **, P < 0.01 versus wt. (D) Representative dot plot analyses showing the results obtained in one of four similar experiments using H2O2 as 
the cell death–triggering stimulus. Percentage indicates the proportion of cells that are propidium iodide and Annexin V double negative (bottom left sec-
tion of the plot), propidium iodide and Annexin V double positive (top right), propidium iodide positive (top left), and Annexin V positive (bottom right). 
(E) Expression of procaspase 9, activated caspase 9, activated caspase 3, and GAPDH as shown by Western blot analysis on myoblasts from wt, Ndn
−/−, 
and MlcNec2 newborn mice maintained for 24 h in growth medium and incubated for 3 h in the presence of 5 μM staurosporine as the cell death–
triggering stimulus.JCB • VOLUME 179 • NUMBER 2 • 2007  316
complexes on the promoter. Necdin has been described to 
behave as a coactivator of transcription mediated by other 
transcription factors such as Dlx2 (Kuwajima et al., 2006), as 
a corepressor, as in the case of E2F-1 (Kuwako et al., 2004; 
Kurita et al., 2006), or as a repressor of Msx2 (Kuwajima 
et al., 2004). Other genes have been described that act as acti-
vators or repressors depending on the molecular partner, as 
observed in the case of Tcf–Groucho versus Tcf–β-catenin 
molecular complexes (Tutter et al., 2001). Here we show that 
necdin is able to directly interact with sequences on the myo-
genin promoter. It has been previously shown that necdin may 
recognize guanosine-rich sequences, similar to the canonical 
GC box recognized by Sp family members (Matsumoto et al., 
2001). Several of these sequences are found in the myogenin 
promoter, in particular around position −170 to 150 from 
the start site and near the binding sites for Mef2 and E boxes 
(de la Serna et al., 2005). We did not detect any direct associa-
tion between necdin and MyoD, Mef2A, or myogenin by co-
immunoprecipitation; this is of relevance and suggests that necdin 
acts directly on these sequences, perhaps with other interacting 
proteins on the promoter to enhance myogenin transcription.
As previously shown in different cell types, we also pro-
vide evidence that necdin interacts with p53 in differentiating 
myoblasts (Taniura et al., 1999; unpublished data). Many stud-
ies support the hypothesis that p53 is activated during myogenic 
differentiation and participates with MyoD to promote myogen-
esis (Tamir and Bengal, 1998; Porrello et al., 2000). In addition 
to acting directly on myogenin transcription, necdin may also 
cooperate with p53. Nevertheless, because p53 expression is not 
essential for muscle development and regeneration (Donehower 
et al., 1992) we hypothesize the role of necdin to be complex.
More studies will be required to get defi  nitive insight into 
the ability of necdin to bind the myogenin promoter, to charac-
terize necdin molecular partners in myogenic precursor cells 
and during skeletal muscle differentiation, and to clarify its role 
in the stabilization of other transcriptional complexes.
Necdin and cell death
Upon muscle injury, disruption of the myofi  ber sarcolemma, 
resulting in increased myofi  ber permeability, leads to generation 
of several proapoptotic cues, including the release of free radi-
cals or other oxidants by activated macrophages (Fielding et al., 
1993; Tidball, 2005) that can promote additional muscle dam-
age (Hampton et al., 1998; Tidball, 2005) by stimulating apop-
tosis of myogenic cells. Two major forms of apoptotic cell death 
have been identifi  ed. The extrinsic pathway is initiated by extra-
cellular insult, which triggers receptor (e.g., Fas)-mediated 
caspase 8 cleavage and activation, which, in turn, catalyses cleav-
age of the downstream effector caspase 3 that acts on a series 
of protein targets, initiating the cellular changes leading to ir-
reversible apoptotic cell death (Ashe and Berry, 2003). The in-
trinsic death pathway is activated by intracellular events, factors 
such as DNA damage, resulting in mitochondrial-mediated cell 
death (Saelens et al., 2004). Proapoptotic members of the Bcl-2 
family, such as Bax and Bid, undergo conformational change, 
oligomerization, and translocation to the mitochondria, result-
ing in cytochrome c release that ultimately induces caspase 9 
cleavage and activation; activated caspase 9 in turn activates 
caspase 3 (Twiddy et al., 2004).
Our studies revealed that necdin acts as a prosurvival 
factor in muscle cells. In particular, myogenic precursor cells 
from both necdin-overexpressing MlcNec2 mice and C2C12 
cells were protected from apoptosis induced by three differ-
ent stimuli (radiation, hydrogen peroxide, and staurosporine), 
whereas cell death of Ndn
−/− myoblasts was greatly increased, 
indicating that necdin acts as an antiapoptotic agent. This ob-
servation in vitro correlates with the fact that in the crushed 
muscle of Ndn
−/− mice, delayed regeneration is accompanied by 
an increased number of TUNEL-positive cells, some of which 
corresponded to myogenic precursors. Conversely, MlcNec2 
mice show a decreased number of TUNEL-positive cells in 
the crushed muscle. A prosurvival role of necdin consistent 
with the one we show here has also been described in neurons 
(Muscatelli et al., 2000; Andrieu et al., 2006; Kurita et al., 
2006) where caspase 3 was found to be activated; however, 
the molecular mechanisms that regulate this action of necdin 
and the relationship to differentiation were unclear. Here we 
show that in addition to caspase 3 activation, caspase 9 was 
greatly activated in the Ndn
−/− cells, whereas when necdin 
was overexpressed in both primary myoblasts or in C2C12, 
there was a dramatic reduction in caspase 9 activation and 
a subsequent reduction in activated caspase 3. This observa-
tion establishes for the fi  rst time a link between necdin and 
the extrinsic, caspase 9–dependent apoptosis pathway. In ad-
dition, our observation that necdin actively protects from 
a variety of different proapoptotic stimuli suggests that it 
switches off the entire apoptotic program triggered in mus-
cle rather than acting as a simple negative modulator of 
selected apoptotic signals; thus it presumably acts by limiting 
events in the common pathway to apoptosis converging on 
caspase 9 activation.
More studies will be needed to clarify whether the anti-
apoptotic role of necdin is mainly related to its transcriptional 
or cotranscriptional activity, mediated, e.g., by interaction with 
p53, or through a direct interaction with the apoptotic pathway 
in the cytosol.
In conclusion, we identify necdin as a novel, important 
factor required for proper myoblast differentiation in vitro and 
in vivo, for the fi  rst phase of muscle fi  ber growth, and for effi  -
cient repair upon muscle injury. We also show that necdin acts 
at different levels: it cooperates to promote the transcriptional 
activation of myogenin by direct binding to the promoter, and 
possibly by contributing to p53 action, and by accelerating 
myoblast differentiation. In addition, it exerts a prosurvival, 
antiapoptotic action in vitro and in vivo, counteracting the 
cytotoxic effect of several apoptotic agents, including the forma-
tion of oxidant species. This necdin prosurvival action can 
explain: (a) the protection of myogenic precursor cells from 
apoptosis in vitro; (b) the accelerated regeneration in vivo in 
necdin gain-of-function mice; and (c) the dramatic loss of the 
muscle regeneration capacity of the necdin null mice. This 
may derive either from the loss of myogenic precursors through 
cell death and/or from secondary muscle damage caused by 
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Materials and methods
Materials
The following reagents were purchased as indicated: anti-necdin pAb from 
Upstate Biotechnology; anti–glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) mAb from Biogenesis; anti-MyoD mAb from DakoCytomation; 
anti-PCNA mAb, anti-MyoD, anti-Mef2A, and anti-Myf5 pAbs from Santa 
Cruz Biotechnology, Inc.; antisarcomeric myosin MF20, antimyogenin, 
and anti-Pax7 mAbs from Developmental Studies Hybridoma Bank; anti-
developmental MyHC (NCL-MyHCd) from Novocastra; antilaminin and anti-
Myc from Sigma-Aldrich; anti-GFP from Invitrogen; and antiactivated 
caspase 3 pAb and anti–caspase 9 mAb (recognizing activated and non-
activated forms) from Cell Signaling. In immunoﬂ  uorescence analysis, pri-
mary antibodies were detected by appropriate Alexa-conjugated (Alexa 
489 or Alexa 594) secondary antibodies (Invitrogen). In immunoblot anal-
ysis, primary antibodies were detected by chemiluminescence with appro-
priate horseradish peroxidase–conjugated secondary antibodies (Bio-Rad 
Laboratories). Cell culture media and sera were purchased from Cambrex. 
Bicinchoninic acid–based assay was purchased from Perbio. The Hoechst 
dye, CTX, and other chemicals were purchased from Sigma-Aldrich.
Animals
Transgenic mice were generated by injecting the puriﬁ  ed linearized con-
struct represented in Fig. 2 A (as in Gordon [1993]) into the pronuclei of 
fertilized oocytes (CBA/C57BL6 F1).
Transgenic mice were identiﬁ  ed by PCR analysis of tail DNA using 
the following primers: TgMex2 forward: 5′-G  T  G  T  C  A  A  G  G  T  T  C  T  A  T  T  A  G  G  -
C  A  C  T  A  -3′; and TgNec reverse: 5′-G  G  T  C  A  A  C  A  T  C  T  T  C  T  A  T  C  C  G  T  T  C  -3′.
Expression of the transgene in the various tissues was evaluated by 
Western blot using the necdin antibody or by RT-PCR (see Protein extraction 
and immunoblot analysis and RT-PCR sections).
Lines were established from two founders, MlcNec2 and Nec9, that 
exhibited correct overexpression of necdin only in the skeletal myoblasts 
and skeletal muscle and were maintained on a CBA/C57BL6 background 
or backcrossed on a C57BL6 background. MlcNec2 and MlcNec9 on 
both backgrounds show the same phenotype in terms of muscle morphol-
ogy and myoblast behavior; therefore, in this work we only considered 
results obtained using the MlcNec2 line.
Ndn
−/− mice (provided by F. Muscatelli) were genotyped by PCR 
analysis of tail DNA using the following primers: Ndn-KO-S: 5′-T  C  T  C  A-
T  G  C  T  T  G  A  A  C  T  G  C  A  -3′; Ndn-KO-AS: 5′-C  A  G  G  T  A  A  T  T  C  T  G  C  T  G  G  A  C  -3′; 
NECF1: 5′-G  T  C  C  T  G  C  T  C  T  G  A  T  C  C  G  A  A  G  G  -3′; and TgNec reverse: 5′-G  G  T-   
C  A  A  C  A  T    C  T  T  C  T  A  T  C  C  G  T  T  C  -3′.
Mice were also crossed with CBA mice and maintained on either a 
pure C57BL6 or a CBA/C57BL6 background. In some experiments, mice 
were crossed with Myf5
nLacZ/+ mice (provided by S. Tajbakhsh,Pasteur 
Institute, Paris, France).
Primary myoblast cell culture and infection
Isolation of primary myoblasts. Primary myoblasts from newborn mice of 
the different strains were isolated as described in Cossu et al. (1980) 
and plated at clonal density. Cells were grown either in proliferation 
medium (DME supplemented with 20% FBS, 3% chick embryo, 100 U/ml 
penicillin, 100 μg/ml streptomycin, and 50 μg/ml gentamycin) or in dif-
ferentiation medium (DME supplemented with 2% horse serum, 100 U/ml 
penicillin, and 100 μg/ml streptomycin). We observed that already 
after 24 h in proliferation medium some cells started to express MyLC 
and MyHC.
Single ﬁ  ber preparation. Single myoﬁ  bers were prepared from 
the extensor digitorum longus and TA muscles of 6–12-wk-old mice as 
described by Rosenblatt et al. (1995; two animals of each strain for 
experiments). Individual myoﬁ  bers were plated on matrigel-coated wells 
of a 24-well multiwell in proliferating medium (20% FBS, 10% horse 
serum, and 1% chick embryo extract in DME) or switched to differentia-
tion medium (2% FCS, 10% horse serum, and 0.5% chick embryo extract 
in DME).
Fibers and myoblasts that exit the ﬁ  bers were ﬁ  xed for immunoﬂ  uor-
escence experiments at different stages of activation and differentiation.
The necdin lentiviral vector (in pRRLsin.PPT.CMV.NTRiresGFPpre) 
was generated and prepared as described in Brunelli et al. (2004). The ﬁ  -
nal MOI was 10
7 TU/ml. After 24 h in culture, myoblast cells were infected 
with an MOI of 100 in proliferation medium overnight. The next day, the 
medium was changed and cells were maintained in proliferation medium. 
Immunoﬂ  uorescence was performed after 72 h, using antibodies speciﬁ  c 
for sarcomeric myosin and GFP.
Histology and immunohistochemistry
TA, diaphragm, or soleus muscles were dissected from adult mice (2–3 mo) 
and frozen in liquid N2–cooled isopentane. 8-μm serial muscle sections 
were either stained with H&E or Azan Mallory or immunostained as 
described in Sciorati et al. (2006).
Regeneration assay
To evaluate the ability of the satellite cell to participate in the regeneration 
process in vivo, injury was performed on the TA of 3-mo-old MlCNec2, 
Ndn
−/−, and wt mice by injecting 25 μl of 10 μM or 100 μM CTX (four 
animals per group). Mice were killed at 1, 3, 7, 14, or 30 d after the CTX 
injection, and the muscle was collected and either sectioned for histologi-
cal analysis or subject to protein or RNA extraction.
Morphometry
Morphometric analyses were performed on sections collected from similar 
regions of each TA muscle and from the belly of each soleus muscle. Two 
images were captured from each section and Image 1.63 (Scion Corpora-
tion) was used to determine the XSA of 700–1,000 myoﬁ  bers per section.
Cell lines, plasmids, and transfections
C2C12 and 10T1/2 cell lines were obtained from American Type Culture 
Collection. C2C12 and 10T1/2 cells were cultured in DME supplemented 
with 15% FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin (prolifer-
ation medium). C2C12 cells were differentiated in DME supplemented 
with 2% horse serum, 100 U/ml penicillin, and 100 μg/ml streptomycin 
(differentiation medium) as described in Pisconti et al. (2006).
10T1/2 and C2C12 cells were transiently transfected with Lipo-
fectamine Plus reagent (Invitrogen). In brief, 10
5 cells were seeded in triplicate 
on 35-mm dishes, and the next day transfected with 0.5 μg of the reporter 
construct pMyo-1565CAT (Edmondson et al., 1992) and 0.5 μg pCMV-
βGal (CLONTECH Laboratories, Inc.), alone or together with various com-
binations of plasmids mixed as follows: 1 μg pIRESNecdin; 1 μg pEMSV-Myf3 
(Myod1); and 1 μg pIRESNecdin + 1 μg pEMSV-Myf3 (Myod1). Cells 
were grown for 2 d in DME, 10% FCS (or in the case of C2C12 cells, in 
differentiation medium, DME, and 2% horse serum); proteins were then ex-
tracted by repeated freezing–thawing. The levels of CAT protein were de-
termined using an enzymatic immunoassay (CAT-ELISA; Roche Diagnostics). 
Cell extracts were normalized for protein concentration and CAT expres-
sion was further normalized to β-galactosidase activity.
C2C12 cells were also transfected with pIRESNecdin to assess 
effect on differentiation. Immunoﬂ  uorescence was performed after 5 d in 
differentiating medium, using antibodies speciﬁ  c for sarcomeric myosin and 
GFP. Alternatively, C2C12 cells were transfected with pCMV3B-Myc-necdin, 
and coimmunoprecipitation or chromatin immunoprecipitation was performed 
after 48 h in differentiating medium.
Immunoﬂ  uorescence
Immunoﬂ  uorescence on the cell cultures and cryosections was performed 
according to Brunelli et al. (2004), using antibodies speciﬁ  c for necdin, 
sarcomeric myosin MF20, MyoD, MyHCd, laminin, Pax7, Myf5, and GFP. 
For ﬂ  uorescent detection, we used appropriate secondary antibodies con-
jugated with either Alexa 488 (green) or Alexa 594 (red; Invitrogen).
Apoptotic cells on muscle cryostat sections were detected using the 
ApopTag ﬂ  uorescein direct in situ apoptosis detection kit (Intergen).
The fusion index of differentiating myoblasts and C2C12 cells was 
measured as the number of nuclei in sarcomeric myosin–expressing cells 
with more than two nuclei versus the total number of nuclei.
Cell resistance to apoptosis
Satellite cells from the different genotypes were incubated with or without 
100 μM H2O2 or 5 μM staurosporine for 24 h, or exposed to UV light for 
1 min. Cells were detached and stained with ﬂ  uorescein isothiocyanate–
Annexin V and propidium iodide, according to the manufacturer’s instruc-
tions (Bender MedSystems), and analyzed by ﬂ  ow cytometry as described 
in Sciorati et al. (1997). Cells that showed single staining for Annexin V or 
double staining for Annexin V and propidium iodide were considered 
dead cells. Alternatively, cells were lysed 3 h after treatments and ana-
lyzed for expression of activated caspases by Western blot.
Protein extraction and immunoblot analysis
Cells were homogenized in 50 mM Tris/HCl, pH 7.4, 1 mM EGTA, 1 mM 
EDTA, 1% Triton X-100, and protease inhibitor cocktail (Complete; Roche 
Diagnostics) and centrifuged at 1,000 g for 20 min at 20°C to discard 
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Muscle tissues were dissected and homogenized in 100 mM 
NaHCO3, 1 mM EDTA, 2% sodium dodecyl sulfate, and protease inhibitor 
cocktail and centrifuged at 1,000 g for 10 min at 4°C to discard cellular 
debris. Sample preparation and Western blot analyses were performed as 
described in Pisconti et al. (2006).
After electrophoresis, polypeptides were electrophoretically trans-
ferred to nitrocellulose ﬁ  lters (Schleicher & Schuell), and antigens were 
revealed by the respective primary antibodies and the appropriate sec-
ondary antibodies.
Chromatin immunoprecipitation
6 × 10
6 of differentiated C2C12 cells, previously transfected with Myc-
tagged necdin, were treated with 1% formaldehyde and sonicated in 600 μl 
of protease inhibitor–containing buffer. The chromatin was then immuno-
precipitated with, respectively, mouse anti-MyoD (Santa Cruz Biotechnol-
ogy, Inc.), mouse anti-Myc (Sigma-Aldrich), and rabbit anti-necdin (Upstate 
Biotechnology), as in Bodega et al. (2007). The input DNA was an aliquot 
of the supernatant from centrifuged sonicate (DNA size range:  200–
1,000 bp), and the preimmune chromatin was immunoprecipitated with 
normal rabbit and mouse IgG (Santa Cruz Biotechnology, Inc.). After an 
overnight incubation with the antibodies, 10 μl of 20 mg/ml tRNA, 20 μl 
of 10 mg/ml salmon sperm DNA, and 20 μl of protein G–agarose beads 
were added to the 1-ml samples and incubated for 3 h at 4°C with constant 
agitation. The puriﬁ  ed immunoprecipitated DNA was dissolved in 60 μl of 
10 mM Tris-HCl, pH 8.0, and 1 mM EDTA. PCRs were performed with 
GoTaq (Promega) for 40 cycles. The primers used were myogenin forward 
(5′-G  A  A  T  C  A  C  A  T  G  T  A  A  T  C  C  A  C  T  G  G  A  -3′), myogenin reverse (5′-A  C  G  C  C  A-
A  C  T  G  C  T  G  G  G  T  G  C  C  A  -3′), β-actin forward (5′-G  C  T  T  C  T  T  T  G  C  A  G  C  T  C  C  T  T  C-
G  T  T  G  -3′), and β-actin reverse (5′-T  T  T  G  C  A  C  A  T  G  C  C  G  G  A  G  C  C  G  T  T  G  T  -3′).
Coimmunoprecipitation
For detection of necdin interactors, C2C12 cells were transfected with 
pCMV3B-Myc-necdin. Cells were harvested after 48 h in differentiating 
medium and lysed in RIPA buffer containing 50 mM Tris-HCl, pH 7.4, 
150 mM NaCl, 0.1% SDS, 0.5% deoxycholate sodium, 1% NP-40, and 1× 
protease inhibitor mixture (Roche). The 2 mg of lysates were incubated 
overnight at 4°C with 5 μg of polyclonal antibody against necdin (Upstate 
Biotechnology) or rabbit anti-IgG. The complexes were pelleted with 
protein G–Sepharose (Invitrogen), separated by 10% SDS-PAGE, and trans-
ferred to nitrocellulose membrane by electroblotting. The membranes were 
incubated with antibodies against MyoD, Mef2A, myogenin, or Myc, and 
washed and incubated with horseradish peroxidase–conjugated goat 
anti–rabbit and anti–mouse IgGs (Bio-Rad Laboratories). Proteins were 
visualized by the chemiluminescence method (ECL Western blot detection 
reagent; GE Healthcare).
RT-PCR
1 μg RNA, collected from cells or tissues using RNeasy mini (or micro) kit 
(QIAGEN), was converted into double stranded cDNA using the cDNA syn-
thesis kit ThermoScript RT-PCR system (Invitrogen), according to the manufac-
turer’s instructions. The primers used were the following: GAPDH forward: 
T  G  A  A  G  G  T  C  G  G  T  G  T  G  A  A  C  G  G  A T  T  T  G  ; GAPDH reverse: C  A  T  G  T  G  G  G  C  C  A  T  G-
A  G  G  T  C  C  A  C  C  A  C  ; dMyHC forward: A  C  T  G  A  G  G  A  A  G  A  C  C  G  C  A  A  G  A  A  T  G  ; 
dMyHC reverse: A A  G  T  A  A  A  C  C  C  A  G  A  G  A  G  G  C  A  A  G  T  G  A  C  C  ; MyLC1 forward: 
G  A  T  C  A  C  C  T  T  A  A  G  T  C  A  G  G  T ; MyLC1 reverse: gcaacgcttctacctctt; necdin NEC 
F2: 5′-C  A  C  T  G  A  T  A  G  T  T  T  C  T  G  A  C  C  C  A  T  A  C  -3′; NEC R1: 5′-G  C  C  A  G  T  T  G  A  A  G  T  C-
A  T  A  T  G  G  A  G  -3′; necdin transgene TgNec reverse: 5′-G  G  T  C  A  A  C  A  T  C  T  T  C  T  A  T  C-
C  G  T  T  C  -3′; and TgMex2 forward: 5′-G  T  G  T  C  A  A  G  G  T  T  C  T  A  T  T  A  G  G  C  A  C  T  A  -3′.
Image acquisition and manipulation
Fluorescent and phase-contrast images were taken on microscopes (Eclipse 
E600 [Nikon]; Plan Fuor lenses: 10×/0.33, 20×/0.50, and 40×/0.75; 
[Leica AF6000]; lenses: HCX PL FLUOTAR L40×/0.60). Images were ac-
quired using digital cameras (DXM1200 [Nikon]; DFC 350 FX [Leica]) and 
acquisition software (ACT-1 [Nikon]; AF6000 [Leica]). The imaging me-
dium was PBS buffer; images were taken at room temperature. Images 
were assembled in panels using Photoshop 7.0 (Adobe). Images showing 
double or triple ﬂ  uorescence were separately acquired using the appropri-
ate ﬁ  lters, and the different layers were merged with Photoshop 7.0.
Statistical analysis
The results are expressed as means ± SEM; n represents the number of 
individual experiments. Statistical analysis was performed using the analysis 
of variance test. Asterisks in the ﬁ  gures refer to statistical probabilities ver-
sus wt controls, respectively. Statistical probability values of <0.05 were 
considered signiﬁ  cant.
Online supplemental material
Fig. S1 shows coexpression of necdin with Pax7 on single ﬁ  ber, expression 
of necdin on a TA section of adult MlcNec2 mice, and expression of nec-
din and Myf5 on a TA section of Ndn
−/− P5 mice. Fig. S2 shows histology 
of TA of wt, MlcNec2, and Ndn
−/−, 30 d after injection of 100 μM CTX. 
Fig. S3 shows the differentiation of primary myoblasts or C2C12 cells after 
overexpression of necdin. Fig. S4 shows absence of coimmunoprecipita-
tion of necdin with MyoD, myogenin, and Mef2A; costaining of TUNEL-
positive cells and β-galactosidase–positive cells in Myf5
nLacZ/+, Ndn
−/− 
mice after CTX injection; and expression of activated caspase 3 and 9 in 
C2C12 cells overexpressing necdin. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200701027/DC1.
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